2008: RA Animal Models: Potential Therapeutic Targets
Search or Browse by Day

RA Animal Models: Potential Therapeutic Targets

Sunday, October 26, 2008
247
Adult Mesenchymal Stem Cells and Gene Therapy in Inflammatory Arthritis
248
Oral Application Of A Highly Specific MMP-13 Inhibitor Reduces Cartilage Invasion In Three Different Animal Models Of Rheumatoid Arthritis
249
Comparison of The Therapeutic Effects of Two Potent Angiogenesis Inhibitors, VEGF-Trap And Soluble Tie-2 Receptor, in Murine Collagen-induced Arthritis
250
Blocking Of IL-23 By Anti-IL-23R Antibody Attenuated Arthritis And Decreased The Synovial Expression Of IL-17, IL-6, And IL-1β In Collagen-induced Arthritis
251
Visfatin/Nicotinamide Phosphoribosyltransferase (Nampt), is a Novel Target For The Treatment Of Inflammatory Arthritis
252
CCR5 Utilized for Resolution not Initiation of Proteoglycan Induced Arthritis
253
Joint-Targeted Inhibition of the Alternative Pathway of Complement Using CR2-fH Attenuates Collagen Antibody-Induced Arthritis in Mice
254
The Inhibitory Effects Of 17β-estradiol In Experimental Arthritis Are Predominantly Mediated Via Estrogen Receptor-alpha
255
Chemotactic Factors in K/Bxn Serum Transfer Arthritis: Studies on the Roles of Macrophage Migration Inhibitory Factor (MIF), Monocyte Chemotactic Protein-1 (MCP-1), and Keratinocyte-Derived Chemokine (KC)
256
Effects Of VCAM-1 And TNFα Inhibition On The Migratory Potential Of Rheumatoid Synovial Fibroblasts In The SCID Mouse Model Of RA
257
Preclinical Efficacy Studies with a Novel, Orally Active Small Molecule Cytokine Inhibitor for the Treatment of RA
258
Suppressed Inflammatory Arthritis With Chimeric NF-κB And Ets-1 Decoy Oligonucleotide In CAIA Mouse Model
259
Indoleamine 2,3-dioxygenase-expressing Dendritic Cells enriched In Peyer’S Patches Of Orally Tolerized Mice Are Involved In The Generation Of CD4+CD25+regulatory T Cells In CIA Mouse Model
260
Vaccination Against Tnfalpha In Human Tnfalpha Transgenic Mice Is Efficient On Established Disease
261
Mesenchymal Stem Cell Therapy has Significant Clinical Effect in Arthritis
262
ADM And (22-52) ADM Decrease Expression Of ADM Receptors And Inflammation In Collagen-induced Arthritis
263
A Central Anti-inflammatory Role of Carboxypeptidase B in Autoimmune Arthritis
264
Efficacy Of XOMA 052 Anti-IL-1β Antibody In The DBA/1 Mouse Collagen-Induced Arthritis Model
265
Toll-like Receptor Homolog Rp105 Attenuates The Development Of Collagen-induced Arthritis
266
Absence of Sphingosine Kinase 1 Alters Progression of TNF-alpha Induced Arthritis
267
Outcome In Autoimmune Arthritis Is Determined By The Balance Of Anti-inflammatory And Pro-homeostatic Immune Complexes
268
Activation Of Innate Immunity Breaks Tolerance And Induces Autoimmune Arthritis In Genetically Susceptible Mice
269
Highly Efficient Suppression of Destructive Arthritis by Combined Blockade of GM-CSF and IL-17 Pathways in a TNF Alpha-Independent Mouse Model
270
RANKL Inhibition by OPG Prevents Bone Resorption Without Affecting Inflammation in Rat Arthritis: Comparison with Anti-inflammatory Therapies
271
BMP3 Expression May Contribute To Focal Bone Erosion in Rheumatoid Arthritis
272
Il-1 Is Essential For Inflammatory Bone Loss
See more of: ACR Abstract Submission Poster Sessions
<< Previous Session Level | Next Session Level >>